晶型对药物溶出的影响?o 现在日本麒麟在中国申报的应该是25,75ng规格的吧,我们只是想做个六类仿制,12.5mg的只是在日本上市吗... 12.5mg还没有上市,2014年3月提交申请 ・ In March we applied for approval for calcium receptor agonist REGPARA® 12.5mg. In China, we are currently seeking approval of Cinacalcet Hydrochloride (product name in Japan: REGPARA® ), a calcium receptor agonist. (Application filed in October 2011.) In February we received approval for additional indications of hypercalcemia in patients with parathyroid carcinoma, and hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy or who experience recurrent primary hyperparathyroidism following surgery, and for dosage and administration for REGPARA® .查看更多